Is TSMC the Best Semiconductor Stock to Buy Now?
The new administration has launched a slew of tariffs, paused…
Buy
59
ITGR Quote, Financials, Valuation and Earnings
Last price:
$117.51
Seasonality move
:
7.83%
Day range:
$113.42 - $116.09
52-week range:
$104.93 - $146.36
Dividend yield:
0%
P/E ratio:
34.36x
P/S ratio:
2.38x
P/B ratio:
2.40x
Volume:
546K
Avg. volume:
761.9K
1-year change:
-1.01%
Market cap:
$3.9B
Revenue:
$1.7B
EPS (TTM):
$3.36
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
ITGR
Integer Holdings
|
$428.7M | $1.24 | 3.3% | 108.79% | $148.25 |
|
ABT
Abbott Laboratories
|
$10.4B | $1.07 | 5.86% | 68.83% | $140.85 |
|
ATRC
AtriCure
|
$122.9M | -$0.22 | 12.92% | -20.23% | $52.22 |
|
ENOV
Enovis
|
$558.9M | $0.74 | 4.35% | 1731.46% | $64.20 |
|
GMED
Globus Medical
|
$625.9M | $0.74 | 6.09% | 580.52% | $97.46 |
|
IRTC
iRhythm Technologies
|
$153.4M | -$0.94 | 16.26% | -36.86% | $130.92 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
ITGR
Integer Holdings
|
$115.44 | $148.25 | $3.9B | 34.36x | $0.00 | 0% | 2.38x |
|
ABT
Abbott Laboratories
|
$129.89 | $140.85 | $225.3B | 16.98x | $0.59 | 1.76% | 5.41x |
|
ATRC
AtriCure
|
$31.74 | $52.22 | $1.6B | -- | $0.00 | 0% | 3.20x |
|
ENOV
Enovis
|
$32.21 | $64.20 | $1.8B | -- | $0.00 | 0% | 0.84x |
|
GMED
Globus Medical
|
$69.39 | $97.46 | $9.5B | 92.52x | $0.00 | 0% | 3.79x |
|
IRTC
iRhythm Technologies
|
$98.63 | $130.92 | $3.1B | -- | $0.00 | 0% | 5.20x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
ITGR
Integer Holdings
|
37.95% | 1.570 | 22.27% | 1.74x |
|
ABT
Abbott Laboratories
|
22.86% | 0.777 | 7.72% | 1.23x |
|
ATRC
AtriCure
|
12.3% | 2.522 | 4.33% | 2.49x |
|
ENOV
Enovis
|
34.16% | 1.174 | 54.18% | 0.86x |
|
GMED
Globus Medical
|
9.6% | 2.737 | 3.9% | 1.72x |
|
IRTC
iRhythm Technologies
|
87.67% | 0.995 | 22.84% | 5.55x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
ITGR
Integer Holdings
|
$116.8M | $56.1M | 4.57% | 7.65% | 11.43% | $44.1M |
|
ABT
Abbott Laboratories
|
$6B | $1.9B | 24.06% | 32.63% | 19.74% | $2.1B |
|
ATRC
AtriCure
|
$92.6M | -$14.5M | -8.52% | -9.67% | -11.15% | -$8.9M |
|
ENOV
Enovis
|
$307.5M | -$15M | -18.98% | -25.93% | -118.48% | $35.1M |
|
GMED
Globus Medical
|
$393.9M | $77.1M | 2.31% | 2.56% | 11.72% | $193.2M |
|
IRTC
iRhythm Technologies
|
$115.1M | -$4.1M | -17.82% | -100.75% | 1.3% | $12.4M |
Integer Holdings vs. Competitors
-
Which has Higher Returns ITGR or ABT?
Abbott Laboratories has a net margin of 7.28% compared to Integer Holdings's net margin of 84.1%. Integer Holdings's return on equity of 7.65% beat Abbott Laboratories's return on equity of 32.63%.
Company Gross Margin Earnings Per Share Invested Capital ITGRInteger Holdings25.98% $0.90 $2.6B ABTAbbott Laboratories54.97% $5.27 $62B -
What do Analysts Say About ITGR or ABT?
Integer Holdings has a consensus price target of $148.25, signalling upside risk potential of 28.42%. On the other hand Abbott Laboratories has an analysts' consensus of $140.85 which suggests that it could grow by 8.44%. Given that Integer Holdings has higher upside potential than Abbott Laboratories, analysts believe Integer Holdings is more attractive than Abbott Laboratories.
Company Buy Ratings Hold Ratings Sell Ratings ITGRInteger Holdings6 2 0 ABTAbbott Laboratories13 7 0 -
Is ITGR or ABT More Risky?
Integer Holdings has a beta of 1.086, which suggesting that the stock is 8.599% more volatile than S&P 500. In comparison Abbott Laboratories has a beta of 0.803, suggesting its less volatile than the S&P 500 by 19.666%.
-
Which is a Better Dividend Stock ITGR or ABT?
Integer Holdings has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Abbott Laboratories offers a yield of 1.76% to investors and pays a quarterly dividend of $0.59 per share. Integer Holdings pays -- of its earnings as a dividend. Abbott Laboratories pays out 28.62% of its earnings as a dividend. Abbott Laboratories's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios ITGR or ABT?
Integer Holdings quarterly revenues are $449.5M, which are smaller than Abbott Laboratories quarterly revenues of $11B. Integer Holdings's net income of $32.7M is lower than Abbott Laboratories's net income of $9.2B. Notably, Integer Holdings's price-to-earnings ratio is 34.36x while Abbott Laboratories's PE ratio is 16.98x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Integer Holdings is 2.38x versus 5.41x for Abbott Laboratories. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income ITGRInteger Holdings2.38x 34.36x $449.5M $32.7M ABTAbbott Laboratories5.41x 16.98x $11B $9.2B
-
Which has Higher Returns ITGR or ATRC?
AtriCure has a net margin of 7.28% compared to Integer Holdings's net margin of -12.53%. Integer Holdings's return on equity of 7.65% beat AtriCure's return on equity of -9.67%.
Company Gross Margin Earnings Per Share Invested Capital ITGRInteger Holdings25.98% $0.90 $2.6B ATRCAtriCure74.53% -$0.33 $525.6M -
What do Analysts Say About ITGR or ATRC?
Integer Holdings has a consensus price target of $148.25, signalling upside risk potential of 28.42%. On the other hand AtriCure has an analysts' consensus of $52.22 which suggests that it could grow by 64.53%. Given that AtriCure has higher upside potential than Integer Holdings, analysts believe AtriCure is more attractive than Integer Holdings.
Company Buy Ratings Hold Ratings Sell Ratings ITGRInteger Holdings6 2 0 ATRCAtriCure5 0 0 -
Is ITGR or ATRC More Risky?
Integer Holdings has a beta of 1.086, which suggesting that the stock is 8.599% more volatile than S&P 500. In comparison AtriCure has a beta of 1.646, suggesting its more volatile than the S&P 500 by 64.574%.
-
Which is a Better Dividend Stock ITGR or ATRC?
Integer Holdings has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. AtriCure offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Integer Holdings pays -- of its earnings as a dividend. AtriCure pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios ITGR or ATRC?
Integer Holdings quarterly revenues are $449.5M, which are larger than AtriCure quarterly revenues of $124.3M. Integer Holdings's net income of $32.7M is higher than AtriCure's net income of -$15.6M. Notably, Integer Holdings's price-to-earnings ratio is 34.36x while AtriCure's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Integer Holdings is 2.38x versus 3.20x for AtriCure. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income ITGRInteger Holdings2.38x 34.36x $449.5M $32.7M ATRCAtriCure3.20x -- $124.3M -$15.6M
-
Which has Higher Returns ITGR or ENOV?
Enovis has a net margin of 7.28% compared to Integer Holdings's net margin of -125.38%. Integer Holdings's return on equity of 7.65% beat Enovis's return on equity of -25.93%.
Company Gross Margin Earnings Per Share Invested Capital ITGRInteger Holdings25.98% $0.90 $2.6B ENOVEnovis54.82% -$12.05 $3.9B -
What do Analysts Say About ITGR or ENOV?
Integer Holdings has a consensus price target of $148.25, signalling upside risk potential of 28.42%. On the other hand Enovis has an analysts' consensus of $64.20 which suggests that it could grow by 99.32%. Given that Enovis has higher upside potential than Integer Holdings, analysts believe Enovis is more attractive than Integer Holdings.
Company Buy Ratings Hold Ratings Sell Ratings ITGRInteger Holdings6 2 0 ENOVEnovis7 1 0 -
Is ITGR or ENOV More Risky?
Integer Holdings has a beta of 1.086, which suggesting that the stock is 8.599% more volatile than S&P 500. In comparison Enovis has a beta of 1.669, suggesting its more volatile than the S&P 500 by 66.902%.
-
Which is a Better Dividend Stock ITGR or ENOV?
Integer Holdings has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Enovis offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Integer Holdings pays -- of its earnings as a dividend. Enovis pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios ITGR or ENOV?
Integer Holdings quarterly revenues are $449.5M, which are smaller than Enovis quarterly revenues of $561M. Integer Holdings's net income of $32.7M is higher than Enovis's net income of -$703.3M. Notably, Integer Holdings's price-to-earnings ratio is 34.36x while Enovis's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Integer Holdings is 2.38x versus 0.84x for Enovis. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income ITGRInteger Holdings2.38x 34.36x $449.5M $32.7M ENOVEnovis0.84x -- $561M -$703.3M
-
Which has Higher Returns ITGR or GMED?
Globus Medical has a net margin of 7.28% compared to Integer Holdings's net margin of 4.03%. Integer Holdings's return on equity of 7.65% beat Globus Medical's return on equity of 2.56%.
Company Gross Margin Earnings Per Share Invested Capital ITGRInteger Holdings25.98% $0.90 $2.6B GMEDGlobus Medical59.92% $0.19 $4.6B -
What do Analysts Say About ITGR or GMED?
Integer Holdings has a consensus price target of $148.25, signalling upside risk potential of 28.42%. On the other hand Globus Medical has an analysts' consensus of $97.46 which suggests that it could grow by 40.46%. Given that Globus Medical has higher upside potential than Integer Holdings, analysts believe Globus Medical is more attractive than Integer Holdings.
Company Buy Ratings Hold Ratings Sell Ratings ITGRInteger Holdings6 2 0 GMEDGlobus Medical6 4 0 -
Is ITGR or GMED More Risky?
Integer Holdings has a beta of 1.086, which suggesting that the stock is 8.599% more volatile than S&P 500. In comparison Globus Medical has a beta of 1.284, suggesting its more volatile than the S&P 500 by 28.425%.
-
Which is a Better Dividend Stock ITGR or GMED?
Integer Holdings has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Globus Medical offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Integer Holdings pays -- of its earnings as a dividend. Globus Medical pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios ITGR or GMED?
Integer Holdings quarterly revenues are $449.5M, which are smaller than Globus Medical quarterly revenues of $657.3M. Integer Holdings's net income of $32.7M is higher than Globus Medical's net income of $26.5M. Notably, Integer Holdings's price-to-earnings ratio is 34.36x while Globus Medical's PE ratio is 92.52x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Integer Holdings is 2.38x versus 3.79x for Globus Medical. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income ITGRInteger Holdings2.38x 34.36x $449.5M $32.7M GMEDGlobus Medical3.79x 92.52x $657.3M $26.5M
-
Which has Higher Returns ITGR or IRTC?
iRhythm Technologies has a net margin of 7.28% compared to Integer Holdings's net margin of -0.81%. Integer Holdings's return on equity of 7.65% beat iRhythm Technologies's return on equity of -100.75%.
Company Gross Margin Earnings Per Share Invested Capital ITGRInteger Holdings25.98% $0.90 $2.6B IRTCiRhythm Technologies70.03% -$0.04 $737.4M -
What do Analysts Say About ITGR or IRTC?
Integer Holdings has a consensus price target of $148.25, signalling upside risk potential of 28.42%. On the other hand iRhythm Technologies has an analysts' consensus of $130.92 which suggests that it could grow by 32.74%. Given that iRhythm Technologies has higher upside potential than Integer Holdings, analysts believe iRhythm Technologies is more attractive than Integer Holdings.
Company Buy Ratings Hold Ratings Sell Ratings ITGRInteger Holdings6 2 0 IRTCiRhythm Technologies8 2 0 -
Is ITGR or IRTC More Risky?
Integer Holdings has a beta of 1.086, which suggesting that the stock is 8.599% more volatile than S&P 500. In comparison iRhythm Technologies has a beta of 1.450, suggesting its more volatile than the S&P 500 by 44.979%.
-
Which is a Better Dividend Stock ITGR or IRTC?
Integer Holdings has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. iRhythm Technologies offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Integer Holdings pays -- of its earnings as a dividend. iRhythm Technologies pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios ITGR or IRTC?
Integer Holdings quarterly revenues are $449.5M, which are larger than iRhythm Technologies quarterly revenues of $164.3M. Integer Holdings's net income of $32.7M is higher than iRhythm Technologies's net income of -$1.3M. Notably, Integer Holdings's price-to-earnings ratio is 34.36x while iRhythm Technologies's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Integer Holdings is 2.38x versus 5.20x for iRhythm Technologies. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income ITGRInteger Holdings2.38x 34.36x $449.5M $32.7M IRTCiRhythm Technologies5.20x -- $164.3M -$1.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Rocket Lab Vs Intuitive Machines Stock
The commercialization of outer space is now in full swing,…
Is The Trade Desk a Screaming Buy?
One factor that sets programmatic advertising platform The Trade Desk…
Stock Ideas
Sell
48
Is AAPL Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 32x
Sell
43
Is MSFT Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 30x
Sell
40
Is NVDA Stock a Buy?
Market Cap: $2.4T
P/E Ratio: 33x
Alerts
Buy
58
AGX alert for Apr 22
Argan [AGX] is up 3.08% over the past day.
Sell
44
INOD alert for Apr 22
Innodata [INOD] is up 5.26% over the past day.
Sell
44
UHS alert for Apr 22
Universal Health Services [UHS] is up 2.73% over the past day.
